Vivimed Labs Gets Export Order worth over Rs 10 crore For Supply Of Generic COVID-19 Drug Favipiravir
The initial Export order Value is worth over INR 100 Million.;
Advertisement
Hyderabad: Vivimed Labs Limited, a niche Specialty Chemicals and Pharmaceuticals company has announced the manufacturing of "Favulous" tablets 200 mg (Favipiravir) against export order.
Favulous tablets 200 mg (Favipiravir) is used for the treatment of mild to moderate cases of Covid-19.
Favipiravir is the only oral anti-viral treatment approved in various countries for the potential treatment of patients with mild to moderate Covid-19 disease.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.